Research Article

[Retracted] Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis

Table 1

Comparison of baseline data between the two groups.

Relevant factorsO group ()C group ()/

Average age (years)0.303>0.05
BMI0.115>0.05
 Pathological typing0.487>0.05
 Squamous cell carcinoma35 (81.40)40 (75.47)
 Adenocarcinoma8 (18.60)13 (24.53)
FLGO staging0.583>0.05
 I B3 period19 (44.19)26 (49.06)
 II A period24 (55.81)27 (50.95)
 HPV infection rate21 (48.83)20 (37.73)1.195>0.05
Degree of differentiation1.917>0.05
 Low differentiation22 (51.16)20 (37.74)
 Middle differentiation12 (27.91)21 (39.62)
 Highly differentiated9 (20.93)11 (20.75)
Menopause0.527>0.05
 Yes27 (62.79)37 (69.81)
 No16 (37.21)16 (30.19)